• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于与人促胰液素受体的杂交体,对参与神经肽VIP人受体配体激活的表位进行分子定位。

Molecular mapping of epitopes involved in ligand activation of the human receptor for the neuropeptide, VIP, based on hybrids with the human secretin receptor.

作者信息

Olde B, Sabirsh A, Owman C

机构信息

Department of Physiology and Neuroscience, Wallenberg Neuroscience Center, University of Lund, Sweden.

出版信息

J Mol Neurosci. 1998 Oct;11(2):127-34. doi: 10.1385/JMN:11:2:127.

DOI:10.1385/JMN:11:2:127
PMID:10096039
Abstract

Receptors for the neurotransmitter and neuroendocrine peptides, vasoactive intesinal peptide (VIP) and secretin, both belong to the Type B subfamily of G-protein-coupled receptors. This group is evolutionally as well as structurally distinct from the much larger Type A, or rhodopsin-type, subfamily. We have mapped the ligand-activating epitopes of the human VIP1 receptor by the use of hybrid receptor constructs with the human secretin receptor. Twelve chimeras were synthesized the successively replacing portions of the former receptor with corresponding portions of the latter receptor, or by interchanging the first extracellular loops. Each of the different chimeric receptor DNAs were then expressed in murine reporter cells, and their ability to activate cAMP production was investigated on stimulation with the respective natural peptide ligands. We stimulated the reporter cells with secretion or VIP following transient expression of the receptor chimeras. The experiments indicated that there are two molecular domains of importance for the recognition and activation of these peptides, namely, the inner portion of the extracellular tail and the first extracellular loop of the two receptors.

摘要

神经递质和神经内分泌肽血管活性肠肽(VIP)及促胰液素的受体均属于G蛋白偶联受体B型亚家族。该亚家族在进化和结构上均与大得多的A型(视紫红质型)亚家族不同。我们通过使用与人促胰液素受体的杂交受体构建体,绘制了人VIP1受体的配体激活表位。合成了12个嵌合体,依次用后者受体的相应部分替换前者受体的部分,或通过交换第一个细胞外环来实现。然后将每个不同的嵌合受体DNA在小鼠报告细胞中表达,并研究它们在用各自天然肽配体刺激时激活环磷酸腺苷(cAMP)产生的能力。在用受体嵌合体瞬时表达后,我们用促胰液素或VIP刺激报告细胞。实验表明,对于这些肽的识别和激活有两个重要的分子结构域,即细胞外尾部的内部和两个受体的第一个细胞外环。

相似文献

1
Molecular mapping of epitopes involved in ligand activation of the human receptor for the neuropeptide, VIP, based on hybrids with the human secretin receptor.基于与人促胰液素受体的杂交体,对参与神经肽VIP人受体配体激活的表位进行分子定位。
J Mol Neurosci. 1998 Oct;11(2):127-34. doi: 10.1385/JMN:11:2:127.
2
The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors.
Peptides. 1996;17(5):825-9. doi: 10.1016/0196-9781(96)00107-6.
3
Sequences (103-110) and (116-120) of the rat secretin receptor are implicated in secretin and VIP recognition.大鼠促胰液素受体的序列(103 - 110)和(116 - 120)与促胰液素和血管活性肠肽的识别有关。
Ann N Y Acad Sci. 2000;921:362-5. doi: 10.1111/j.1749-6632.2000.tb06994.x.
4
Properties of chimeric secretin and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discrimination.
Biochem Biophys Res Commun. 1995 Jun 26;211(3):885-91. doi: 10.1006/bbrc.1995.1895.
5
Identification of binding domains of the growth hormone-releasing hormone receptor by analysis of mutant and chimeric receptor proteins.通过分析突变体和嵌合受体蛋白鉴定生长激素释放激素受体的结合结构域
Mol Endocrinol. 1998 May;12(5):750-65. doi: 10.1210/mend.12.5.0102.
6
Interaction of amino acid residues at positions 8-15 of secretin with the N-terminal domain of the secretin receptor.促胰液素8-15位氨基酸残基与促胰液素受体N端结构域的相互作用。
Eur J Biochem. 1996 Jul 15;239(2):349-55. doi: 10.1111/j.1432-1033.1996.0349u.x.
7
Construction of chimeras between human VIP1 and secretin receptors: identification of receptor domains involved in selectivity towards VIP, secretin, and PACAP.
Ann N Y Acad Sci. 1998 Dec 11;865:386-9. doi: 10.1111/j.1749-6632.1998.tb11201.x.
8
Critical contributions of amino-terminal extracellular domains in agonist binding and activation of secretin and vasoactive intestinal polypeptide receptors. Studies of chimeric receptors.
J Biol Chem. 1995 Jun 16;270(24):14394-8. doi: 10.1074/jbc.270.24.14394.
9
Role of charged amino acids conserved in the vasoactive intestinal polypeptide/secretin family of receptors on the secretin receptor functionality.血管活性肠肽/促胰液素受体家族中保守的带电荷氨基酸对促胰液素受体功能的作用。
Peptides. 1999;20(10):1187-93. doi: 10.1016/s0196-9781(99)00122-9.
10
Aspartate 196 in the first extracellular loop of the human VIP1 receptor is essential for VIP binding and VIP-stimulated cAMP production.人VIP1受体第一个细胞外环中的天冬氨酸196对于VIP结合及VIP刺激的cAMP产生至关重要。
Biochem Biophys Res Commun. 1997 Jan 13;230(2):289-92. doi: 10.1006/bbrc.1996.5949.

引用本文的文献

1
Refinement of glucagon-like peptide 1 docking to its intact receptor using mid-region photolabile probes and molecular modeling.使用中区域光亲和探针和分子建模对胰高血糖素样肽 1 与其完整受体的对接进行精细化研究。
J Biol Chem. 2011 May 6;286(18):15895-907. doi: 10.1074/jbc.M110.217901. Epub 2011 Mar 16.
2
Mode of coreceptor use by R5 HIV type 1 correlates with disease stage: a study of paired plasma and cerebrospinal fluid isolates.R5型1型人类免疫缺陷病毒共受体使用模式与疾病阶段相关:配对血浆和脑脊液分离株的研究
AIDS Res Hum Retroviruses. 2009 Dec;25(12):1297-1305. doi: 10.1089/aid.2009.0069.

本文引用的文献

1
Method for identifying ligands that bind to cloned G(s)- or G(i)-coupled receptors.鉴定与克隆 G(s)-或 G(i)-偶联受体结合的配体的方法。
Mol Cell Neurosci. 1991 Aug;2(4):331-7. doi: 10.1016/1044-7431(91)90063-t.
2
Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagonlike peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G-protein-linked receptor family.促胰液素、降钙素、甲状旁腺激素(PTH)/甲状旁腺激素相关肽、血管活性肠肽、胰高血糖素样肽 1、生长激素释放激素和胰高血糖素受体属于新发现的 G 蛋白偶联受体家族。
Trends Endocrinol Metab. 1993 Dec;4(10):309-14. doi: 10.1016/1043-2760(93)90071-l.
3
Proceedings of the 2nd International Symposium on VIP, PACAP, and Related Peptides. New Orleans, Louisiana, USA. October 4-7, 1995.
第二届血管活性肠肽、垂体腺苷酸环化酶激活肽及相关肽国际研讨会会议记录。美国路易斯安那州新奥尔良。1995年10月4日至7日。
Ann N Y Acad Sci. 1996 Dec 26;805:1-792.
4
Proposed arrangement of the seven transmembrane helices in the secretin receptor family.促胰液素受体家族中七个跨膜螺旋的拟议排列。
Recept Channels. 1998;5(2):79-90.
5
The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors.
Peptides. 1996;17(5):825-9. doi: 10.1016/0196-9781(96)00107-6.
6
Improvement of the gene splicing overlap (SOE) method.
Biotechniques. 1995 Aug;19(2):186-8.
7
Vasoactive intestinal peptide and helodermin inhibit phospholipase A2 activity in vitro.血管活性肠肽和胃泌酸调节素在体外抑制磷脂酶A2的活性。
Regul Pept. 1993 Nov 3;48(3):301-7. doi: 10.1016/0167-0115(93)90158-5.
8
Generating bacteriophage lambda sublibraries enriched for rare clones.
Biotechniques. 1994 Mar;16(3):420-2.
9
Construction of chimeric molecules by a two-step recombinant PCR method.
Biotechniques. 1994 Jun;16(6):1010-1.
10
Design and development of a vasoactive intestinal peptide analog as a novel therapeutic for bronchial asthma.
Biopolymers. 1995;37(2):57-66. doi: 10.1002/bip.360370203.